Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Chemistry

Compound Libraries for Screening

Our highly curated collections of small molecule libraries consist of a variety of focused and diverse compound collections. A vast number of compounds can be screened in high-throughput assays to identify those that are drug-like or lead-like, with the potential to modulate the target. Our fully integrated approach to compound library design and screening allows our expert chemists with deep industry experience to propel your drug discovery program quickly and seamlessly through hit-to-lead, optimization and beyond.